Nirav Thosani is a Gastroenterology physician affiliated with The University of Texas Health Science Center at Houston. OpenAlex indexes 585 publications with 8,917 citations (h-index 52); ClinicalTrials.gov lists 10 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Gastroenterology profiles in the FindMyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions
Sponsor: The University of Texas Health Science Center, Houston
- Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry
Sponsor: The University of Texas Health Science Center, Houston
- Artificial Intelligence (AI) Cytopathology Trial
Sponsor: The University of Texas Health Science Center, Houston
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
4 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- A single-arm phase II study to evaluate the safety and efficacy of combination systematic chemotherapy and multiple rounds of endoscopic ultrasound-guided radiofrequency ablation in pancreatic cancer
University of Texas Hlth Sci Ctr Houston
FY2026$651,173R01CA277161 - A single-arm phase II study to evaluate the safety and efficacy of combination systematic chemotherapy and multiple rounds of endoscopic ultrasound-guided radiofrequency ablation in pancreatic cancer
University of Texas Hlth Sci Ctr Houston
FY2025$651,173R01CA277161 - A single-arm phase II study to evaluate the safety and efficacy of combination systematic chemotherapy and multiple rounds of endoscopic ultrasound-guided radiofrequency ablation in pancreatic cancer
University of Texas Hlth Sci Ctr Houston
FY2024$621,551R01CA277161
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
John Reveille, MD
The University of Texas Health Science Center at Houston
Martin Citardi, MD
The University of Texas Health Science Center at Houston
John Lincoln, MD
The University of Texas Health Science Center at Houston
Frank Arnett, MD
The University of Texas Health Science Center at Houston
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”